GLUCARDIAMID,125 mg + 1500 mg, tablets
Nicethamide + Glucose
This medicine should always be taken exactly as described in this package leaflet for the patient or as directed by a doctor or pharmacist.
G contains nicethamide and glucose as active substances.
Nicethamide has a stimulating effect on the central nervous system. It increases the sensitivity of the respiratory center to carbon dioxide, increases respiratory volume, and intensifies respiratory rate. By increasing heart rate, cardiac output, and pulmonary artery pressure, it raises blood pressure, especially in patients with hypotension.
The glucose contained in the medicine G serves as an energy source for the body.
G can be used as an auxiliary agent:
Before starting to take G, the patient should discuss it with their doctor or pharmacist.
The following conditions require cautious use (only in consultation with a doctor):
Nicethamide is on the list of doping substances in sports, prepared by the Anti-Doping Commission. It may cause positive results in some anti-doping tests.
Do not use in children under 12 years of age.
The patient should inform their doctor or pharmacist about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take.
No interactions between G and other medicines have been observed at recommended doses.
The medicine should be used with caution in patients taking sympathomimetic drugs and monoamine oxidase inhibitors, as well as in combination with muscle relaxants.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before taking this medicine. The use of G is not recommended during pregnancy and breastfeeding due to the lack of safety confirmation.
The medicine does not affect psychophysical abilities, the ability to drive vehicles, or operate machinery.
If the patient has previously been diagnosed with intolerance to certain sugars, they should consult their doctor before taking the medicine. The medicine may have a harmful effect on teeth.
The medicine may cause allergic reactions.
The medicine may cause local irritation of the mucous membranes.
This medicine should always be taken exactly as described in this package leaflet for the patient or as directed by a doctor or pharmacist. In case of doubts, the patient should consult their doctor or pharmacist.
Oral administration.
Recommended dose:
Suck 4 to 6 tablets per day.
Even if the patient swallows several tablets whole, G is released slowly, and a significant amount of the medicine is eliminated during this time.
In the event of significant overdose, the following symptoms may occur: accelerated breathing, nausea, vomiting, excessive sweating, itching, sneezing, anxiety, and seizures. Other symptoms include dizziness, headache, anxiety, disorientation, flushing, high fever, sweating, and paresthesia, as well as a feeling of heat. More severe overdose symptoms include increased blood pressure, muscle spasticity, sinus tachycardia, and other arrhythmias, as well as seizures.
The patient should continue taking the medicine without increasing the next dose.
A double dose should not be taken to make up for a missed dose.
Like all medicines, G can cause side effects, although not everybody gets them.
Side effects may manifest as: lowered seizure threshold, persistent cough, bronchospasm, and headache.
More severe side effects include the exacerbation of porphyria symptoms, a disease characterized by episodic abdominal pain, neurological and psychiatric disorders.
If the patient experiences any side effects, including any possible side effects not listed in this leaflet, they should inform their doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products:
Al. Jerozolimskie 181C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help gather more information on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
Store in a temperature below 25°C.
Store in the original packaging to protect from moisture.
Do not use this medicine after the expiry date stated on the carton after the words "Expiry date". The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Tablets in the shape of flat cubes made of transparent, yellow mass, packaged separately in aluminum/paper/PE laminate, in a cardboard box.
The package contains 10 or 20 tablets.
Marketing authorization holder:
Perrigo Poland Sp. z o.o.
ul. Domaniewska 48
02-672 Warsaw
{logo Perrigo}
Manufacturer:
Przedsiębiorstwo Produkcyjno – Handlowe „EWA” S.A.
ul. Zamkowy Folwark 9
63-700 Krotoszyn
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.